地塞米松治疗小儿大叶性肺炎的临床效果

Abstract
Figure/Table
References (16)
Related Citation (15)

Download: PDF (0 KB) HTML (33 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To explore the clinical effect of Dexamethasone (DMXS) in the treatment of lobar pneumonia.Methods A total of 102 children with lobar pneumonia treated in our hospital from June 2018 to June 2019 were selected as subjects and divided into two groups through stratified sampling method,51 cases in each group.The control group received routine treatment measures such as anti infection,cough and asthma relief;on the basis of routine treatment,the study group took DMXS.The curative effect,symptom relief time,hospital stays and inflammatory factors were compared between the two groups. Results The total effective rate in the study group (92.16%) was higher than that of control group (78.43%),with statistical difference (P<0.05);the relief time of symptoms like high fever,cough and lung rale,hospital stays in the study group were shorter than those of control group,with statistical differences (P<0.05).Before treatment,tumor necrosis factor-α(TNF-α),interleukin-8(IL-8)and interleukin-6(IL-6)between groups showed no statistically significant differences (P＞0.05),after treatment,the levels of TNF-α,IL-8 and IL-6 in the study group were lower than those of control group,with statistical differences (P<0.05).Conclusion DMXS can shorten the symptom relief time,improve the inflammatory index and treatment effect,and promote children′s fast recovery.

Key words： Dexamethasone Lobar pneumonia Effect Tumor necrosis factor-&alpha Interleukin-8 Interleukin-6

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	ZHAO Na

Cite this article:

ZHAO Na. Clinical effect of Dexamethasone in the treatment of lobar pneumonia[J]. 中国当代医药, 2020, 27(21): 119-121转125.

URL:

https://dangdaiyiyao.com/EN/ OR https://dangdaiyiyao.com/EN/Y2020/V27/I21/119

[1]	刘红，张联合，吴红艳，等.地塞米松治疗小儿大叶性肺炎的疗效分析[J].中国妇幼健康研究，2015，26（5）：1066-1067，1068.
[2]	方丹枫.阿奇霉素联合小剂量糖皮质激素治疗儿童大叶性肺炎的临床疗效[J].中国妇幼保健，2018，33（1）：127-128.
[3]	于志辉，杨珂.地塞米松联合阿奇霉素治疗小儿肺炎支原体大叶性肺炎的临床疗效[J].临床合理用药杂志，2018，11（27）：62-63.
[4]	万其芳.阿奇霉素联合小剂量激素治疗肺炎支原体大叶性肺炎的疗效[J].实用临床医学，2015，16（5）：11-12.
[5]	吴剑波，何志民.清开灵注射液联合糖皮质激素对大叶性肺炎患者血清IL－10 及TNF-α 水平的影响[J].中国生化药物杂志，2016，36（4）：152-154.
[6]	吴跃进，孙节，张建华，等.糖皮质激素辅助治疗儿童肺炎支原体大叶性肺炎的疗效[J].中国当代儿科杂志，2014，16（4）：401-405.
[7]	杜春艳，卢强，李玉品，等.大叶性肺炎患儿血清肿瘤坏死因子-α、白细胞介素-6、白细胞介素-8、白细胞介素-10和高迁移率族蛋白B1 表达意义[J].中华实用儿科临床杂志，2014，29（16）：1224-1226.
[8]	李里力，曹晓莉.糖皮质激素辅助治疗对大叶性肺炎小儿血清CRP、IL-6 及PCT 水平影响研究[J].中国生化药物杂志，2016，36（2）：48-50.
[9]	张利.小剂量糖皮质激素+阿奇霉素治疗小儿大叶性肺炎的疗效分析[J].海南医学院学报，2018，24（12）：1179-1182.
[10]	楚玉波.糖皮质激素治疗儿童肺炎支原体大叶性肺炎的价值[J].河北医药，2018，40（7）：1077-1079.
[11]	张世坤，赵轲.血清炎症相关因子检测在小儿大叶性肺炎中的临床意义[J].临床肺科杂志，2019，24（5）：835-838.
[12]	杨琳东，张延峰.糖皮质激素辅助治疗儿童肺炎支原体大叶性肺炎的疗效分析[J].河北医学，2017，23（7）：1135-1139.
[13]	古智兵，王俭，万光平，等.阿奇霉素联合小剂量糖皮质激素对儿童大叶性肺炎炎症相关指标影响分析[J].中华医院感染学杂志，2017，27（17）：4012-4015.
[14]	李朗，郭平，江德琴，等.糖皮质激素辅助治疗儿童肺炎支原体感染性大叶性肺炎的临床疗效[J].中国妇幼保健，2017，32（14）：3225-3227.
[16]	廖笑玲，吴亮.地塞米松辅助治疗小儿大叶性肺炎的临床疗效及对炎症因子、血沉的影响[J].中华全科医学，2017，15（5）：817-819.
[15]	Li Y，Han F，Yang Y，et al.Principles of antibiotic application in children with lobar pneumonia：step-up or stepdown[J].Exp Ther Med，2017，13（6）：2681-2684.